My ePortfolio Register   
Symptom management: Confusion and Delirium - Text version

Symptom management: Confusion and Delirium - Text version

en English

Only available as part of a course
Proceed to module  Shortlist  Rate Module  Share
Language

en English

Summary This module from the e-learning course in India Palliative Care has been developed in partnership with Karunashraya Hospice, Bengaluru and Cardiff Palliative Care Education Team, Wales.
Description

This text version of the Symptom management: Confusion and Delirium module is part of the India Palliative Care course which has been developed in partnership with Karunashraya Hospice, Bengaluru and Cardiff Palliative Care Education Team, Wales. Experts from across India and the UK have contributed to ensure the course is appropriate for the India cancer profile and resource setting.

This module was published in May 2016.

THIS E-LEARNING MODULE RUNS BEST ON MOZILLA FIREFOX AND INTERNET EXPLORER 7 AND ABOVE WITH FLASH ENABLED.

Target Audience

Multi-disciplinary Indian healthcare professionals.

Learning Objectives

By the end of the module, you should be able to:

  • Correctly diagnose confusion/delirium and identify likely possible causes.
  • Outline an appropriate a management plan for such a patient.
  • Share your knowledge with a new team member by leading an education session.
Only available as part of course(s):

Text only version of the palliative care e-learning course for healthcare professionals in India

IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on INTERNET EXPLORER 7 AND ABOVE, and MOZILLA FIREFOX on either Windows or MacOS. FLASH ADD ON is also required to run this module.

Proceed to Module

Relevant to the following professions

  • Nurse
  • Oncologist
  • Other
Proceed to module  Shortlist  Rate Module


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence